Keep It Quick Reviews

[qwertytrader]

Stock Split Plays $AMZN $FTNT $GOOG $GOOL

Amazon = In after
Fortinet Inc = Will wait till after
Google = In before

[qwertytrader]

Shareholder Information iShares Silver Trust

iShares® Silver Trust
The iShares Silver Trust (the “Trust”) issues shares (“Shares”) representing fractional undivided beneficial interests in its net assets. The assets of the Trust consist primarily of silver held by a custodian on behalf of the Trust. The Trust seeks to reflect generally the performance of the price of silver. The Trust seeks to reflect such performance before payment of the Trust’s expenses and liabilities.

The Shares are listed and trade on NYSE Arca, Inc. (“NYSE Arca”) under the ticker symbol “SLV”. Market prices for the Shares may be different from the net asset
value per Share. iShares Delaware Trust Sponsor LLC (the “Sponsor”) is the sponsor of the Trust, The Bank of New York Mellon (the “Trustee”) is the trustee of the Trust, and JPMorgan Chase Bank N.A., London branch (the “Custodian”), is the custodian of the Trust. The Trust is not an investment company registered under the United States Investment Company Act of 1940, as amended (the “Investment Company Act”). The Trust is not a commodity pool for purposes of the United States Commodity Exchange Act of 1936, as amended (the “Commodity Exchange Act” or “CEA”).


The Trust intends to issue Shares on a continuous basis. The Trust issues and redeems Shares only in blocks of 50,000 or integral multiples thereof. A block of 50,000 Shares is called a “Basket.” These transactions take place in exchange for silver. Only registered broker-dealers that become authorized participants by entering into a contract with the Sponsor and the Trustee (“Authorized participants”) may purchase or redeem Baskets. Shares will be offered to the public from time to time at prices that will reflect the price of silver and the trading price of the Shares on NYSE Arca at the time of the offer. On January 28, 2022, the Shares closed on NYSE Arca at $20.71 and the LBMA Silver Price (as defined in “Business of the Trust – Valuation of Silver; Computation of Net Asset Value) was $22.50 per ounce. Except when aggregated in Baskets, Shares are not redeemable securities. Investing in the Shares involves significant risks. See “Risk Factors” starting on page 6.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the
securities offered in this prospectus, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal
offense.

The Shares are not interests in nor obligations of either the Sponsor or the Trustee.

“iShares” is a registered trademark of BlackRock, Inc. or its affiliates.
The date of this prospectus is January 31, 2022.

[qwertytrader]

See what I mean about cash position - See Gene Munster from Loup Ventures

SOURCE

[qwertytrader]

Cash Heavy Position into Q3/4 2022 & Q1-3 2023 - READY TO INVEST

Many american companies are going to show lower revenue and forecasts, be ready for their dips.

WHY???? Great Question
Recession Coming

https://fortune.com/2022/05/16/goldman-sachs-recession-forecast-spx-stocks-crypto/

https://www.barrons.com/advisor/articles/what-advisors-are-saying-about-possible-recession-51652750403

https://www.cnbc.com/2022/05/05/main-street-is-more-sure-than-wall-street-a-recession-is-coming.html

https://www.usatoday.com/story/money/2022/05/04/recession-2022-deutsche-bank/9587562002/?gnt-cfr=1

Foreign Buying Shortage:
https://www.bloomberg.com/news/articles/2022-05-06/china-orders-government-state-firms-to-dump-foreign-pcs#:~:text=China%20has%20ordered%20central%20government,within%20its%20most%20sensitive%20organs

[qwertytrader]

Weasel CNBC Playing Contrarian

GET YOUR MONEY THANNNN TELL YA THE TRUTH




DO NOT BE FOOLED - They are mixing in what you want to hear with what you need to hear. PLAYING BOTH SIDES.

SOURCE:

[qwertytrader]

Major CNBC PUMP UNDERWAY

SOURCE

MORE SOURCE FOR THIS TRASH

Don't be part of the debt resolution process.

IMO = Cash position until bottom.

ROBINHOOD - Great cost per trade company. BBBBBBut you can not trade beyond 3 trades n 5 days without a 25K cash/stock/equities/NON CRYPTO position. Otherwise you will be labeled a day trader and locked for 90 days!

SOURCE
https://cdn.robinhood.com/assets/robinhood/legal/RHF%20Fee%20Schedule.pdf

[qwertytrader]

How much of your portfolio should be cash?

Kristen of Citi Global answer: "none"

STAY AWAY FROM HER ADVICE - The market is going to correct the governments debt gap at your portfolios expense in the near term. Cash position will allow you to make money when they are done eating the meat of the bones of the retail investor.

[qwertytrader]

Housing Market Peaked - American dream of owning a home is no longer the American dream for the masses.

BANKS and LENDER stocks will go down. P/E correction based on forward looking earnings = lower PRICE

Inflation Spiked Worse-Than-Expected 8.3% In April—But Have Surging Prices Finally Peaked?
https://www.forbes.com/sites/jonathanponciano/2022/05/11/inflation-spiked-83-in-april-have-surging-prices-finally-peaked/?sh=a4cfc402f4e9

Canadian home prices fall 6% in April, down for 2nd month in a row
https://www.cbc.ca/news/business/housing-prices-april-1.6454728

We’re seeing an inflection point in the housing market, says Ivy Zelman

[qwertytrader]

TECH GOING TO MOVE LOWER BC OF CHINA 2022 - 2023

WHY =

China has ordered central government agencies and state-backed corporations to replace foreign-branded personal computers with domestic alternatives within two years, marking one of Beijing’s most aggressive efforts so far to eradicate key overseas technology from within its most sensitive organs.

SOURCE:
https://www.bloomberg.com/news/articles/2022-05-06/china-orders-government-state-firms-to-dump-foreign-pcs#:~:text=China%20has%20ordered%20central%20government,within%20its%20most%20sensitive%20organs.

[qwertytrader]

FASB to Consider Setting Rules on Companies’ Crypto Accounting, Disclosure
The decision represents a turnaround at the U.S. standard-setter, which for years declined to take up the issue of crypto accounting

https://www.wsj.com/articles/fasb-to-consider-setting-rules-on-companies-crypto-accounting-disclosure-11652297711

As soon as companies can hold crypto on the books the price is going to increase.

[qwertytrader]

Opinion Learning P/E Ratio vs Earning

Many would argue, like William O'Neil, that just because a stock trading at the low end of the yearly P/E range does not make it a good investment.

They would continue to argue we should consider whether the rate of change in earning is substantially increasing or decreasing.

They would however use P/E to guess the potential price objective of a growth over the next 6 to 18 months based on its estimated future earnings.

TL/DR
Earnings and future earnings are the leading indicator when utilizing the P/E ratio in stock valuation.

[qwertytrader]

Big Tech PE Valuations 3/2020 vs 1/2022
Pandemic Lows to All Time Highs

APPLE - GOING DOWN IMO
3/2020 = 17x
1/2022 = 30x
FWD PE 24.11

MICROSOFT
3/2020 = 23x
1/2022 = 34x

ALPHABET - GOING DOWN IMO
3/2020 = 22x
1/2022 = 25x
FWD PE 20.56

AMAZON - THIS IS SUSPICIOUS
]3/2020 = 58x
1/2022 = 65x
FWD PE 67.54

META/FACEBOOK - GOING DOWN IMO
3/2020 = 18x
1/2022 = 24x
FWD PE 16.84

source CNBC Interview with Dan Ives on 5/13/22

[qwertytrader]

$BTC Chart 051522 - Waiting for an entry point while considering small bites.

[qwertytrader]

Solana $SOL Chart [5/14/22]

[qwertytrader]

Stock Watchlist $DOCU $TDOC $EXFY $BLK $HOOD $BAC $JPM $WFC $PG $TSLA $AMZN $GOOGL

[qwertytrader]

Crypto Watch List $BTC $ETH $SOL $SHIB $DOGE

[qwertytrader]

Welcome Back Folks - Board is being updated.

[newmedman]

what happened?

[UserAlias1]

$IMUC corporate update tomorrow..

[fast.money]

$ZNTR is on watch for Monday. chatters are picking up over the weekend. Bottom bouncer?

[GoAndCollect]

UStream is beaten already !!!

Global Rank
Global rank icon 1,099,724 537,568
Rank in United States
United States Flag 316,756


Daily Pageviews per Visitor
1.00 1.00%
Daily Time on Site
0:28 46.00%

Lol we are aready 4 times higher

Livestream.com and youtube.com left ... lol

[qwertytrader]

the action was great $$$ $SEEK

[Silverblue]

make money with SEEK

[mquattrini]

Merger with USG1 has taken place.

Canwealth has just filed the S-1 and we are now waiting.

Follow and ask question on this board:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=89736214

Cheers.

[qwertytrader]

Special Note for $DRL

I am a fan of $DRL as a stock over the years - however as I do some home reading I have taken notice of the following

very interesting

To authorize and approve an amendment to our Restated Certificate of Incorporation, as amended (“Certificate of Incorporation”), to effect a reverse stock split of our outstanding common stock at a ratio within the range of one-for-fifteen (1:15) to one-for-twenty-five (1:25) (the “Reverse Stock Split”), together with the corresponding proportional reduction (based on the Reverse Stock Split ratio selected by our Board of Directors) in the number of authorized shares of our Common Stock (the “Authorized Share Reduction”);

http://ih.advfn.com/p.php?pid=nmona&article=57484646

[qwertytrader]

Qwerty is going: Electric Daisy Carnival

[qwertytrader]

$AEYE - AudioEye Inc Information & Links


Founded in 2003, AudioEye, Inc. (AudioEye) ...

AudioEye is focused on innovation and creating voice driven technologies that will improve the mobility, usability and accessibility of all Internet based content. We offer our solutions in three distinct product groups:
AudioEye Mobile
AudioEye Internet
AudioEye Technology Licensing

Our company is headquartered at the University of Arizona Science and Technology Park in Tucson, Arizona and maintains business development office in the John Hancock building in Chicago, Illinois.

What is AudioEye Technology?

AudioEye is a breakthrough patented voice infrastructure technology.

Our patented technology dramatically expands the power and functionality of the voice-controlled browser. Voice recognition and artificial intelligence engines provide a partial solution, allowing users to get an "answer" to a specific question. Our patented technologies enable an essential third ingredient – delivering audio menus that allow users to choose among multiple responses and navigate the Internet via keypad or voice just as they would with familiar mouse/icon or gestural interfaces.

Our technology Platform, when connected to voice recognition and artificial intelligence engines, can provide for a fully Audio Internet (TM) experience complete with voice navigation and voice driven transactions. Everything the Internet can do AudioEye can do better without the use of a visual display, mouse, or touch pad.

++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++



CORPORATE
University of Arizona
Science & Technology Park
9070 S. Rita Road, Suite 1450
Tucson, Arizona 85747
Toll Free: 866.331.5324
Fax: [phone]
[e-mail]

++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++


Governance

BOARD MEMBERS

Craig Columbus
Chairman

Dr. Carr Bettis
Independent Director

Edward Withrow III
Independent Director

Nathaniel T. Bradley
Chief Executive Officer, Director

Sean Bradley
CTO & President and Director

James Crawford
Chief Operating Officer and Director

ADVISORY BOARD
Harry Epstein
Barry Goldwater Jr
Michael Axelrod
Paul Arena

++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

Quote:
http://ih.advfn.com/p.php?pid=squote&symbol=AEYE

iHub Board:

http://investorshub.advfn.com/AudioEye-Inc-AEYE-26369/

OTC Markets

http://www.otcmarkets.com/stock/AEYE/quote

SEC
AUDIOEYE INC CIK#: 0001362190

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001362190&owner=exclude&count=40&hidefilings=0

StockChart
http://stockcharts.com/

http://stockcharts.com/c-sc/sc?s=AEYE&p=D&b=5&g=0&i=t27740880559&r=1368233300265

++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++



Capabilities
AudioEye® invents, manufactures and distributes mobile, advertising and Internet technologies that enable users to transact, communicate, and engage with products, brands, and content using networked interactive voice technology


Differentiators

AudioEye® owns an exclusive patent portfolio comprised of three issued patents in the United States, as well as several U.S. patents pending with the U.S.P.T.O. AudioEyes® patent portfolio encompasses over sixty issued claims that canvass Internet and mobile markets.

Current United States Patents pending patent applications owned and being prosecuted by AudioEye®:

• Title: “SYSTEM AND METHOD FOR AUDIO CONTENT GENERATION”
Continuation application filed with the U.S. Patent and Trademark Office on 05/02/2011

• Title: "SYSTEM AND METHOD FOR AUDIO CONTENT NAVIGATION“
Continuation application filed with the U.S. Patent and Trademark Office on 08/25/2011AudioEye®, Inc. is focused on developing and monetizing its proprietary innovations in the field of networked and device embedded audio technology. Three issued patents include:

• Audio Content Navigation: U.S. patent #7653544
“Method and Apparatus for Website Navigation by the Visually Impaired”

• Mobile Navigation and Audio Publishing: U.S. patent #7966184
“System and Method for Audible Web Site Navigation”

• Audio Internet Patent : U.S. patent #8046229
“Method and Apparatus for Website Navigation by the Visually Impaired”

Past Performance

• Congressman Raul Grijalva used Audioeye’s patented, multi-format publishing technology to meet all government requirements (Section 508 of the Rehabilitation Act) and Complete Website Accessibility.
• The University of Arizona’s Eller School of Management has utilized the Audioeye system to ensure its curriculumand data are accessible to all end users.
• Arizona State Senator Linda Lopez used Audioeye’s patented, multi-format publishing technology to meet all government requirements (Section 508 of the Rehabilitation Act) and Complete Website Accessibility.

GSA Information
GSA PENDING

CAGE
6DY14

DUNS
006337918

NAICS
541512
Computer Systems Design Services

541511
Custom Computer Programming
Services

541519
Other Computer Related Services

Primary Contacts

POC: Jim Crawford
Email: [e-mail]
Phone: [phone]

Alternate POC: Nathan Bradley
Email: [e-mail]
Phone: [phone]

Locations
Chicago - John Hancock Center
875 North Michigan Avenue
Suite 2626
Chicago, IL 60611

University of Arizona
Science & Technology Park
9070 S. Rita Road, Suite 1450
Tucson, Arizona 85747

++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

Testimonial: U. S. Rep. Raúl M. Grijalva (AZ-07)



www.grijalva.house.gov

"AudioEye has been an important part of my efforts to connect with constituents for several years now, and I can't thank them enough for their good work. It's important to me to maintain strong relationships with local businesses, and AudioEye offers a good product straight from Southern Arizona that thousands of my Web site visitors have enjoyed. I hope they keep growing and providing solutions for many years to come."

Adam Sarvana
Communications Director
U. S. Rep. Raúl M. Grijalva (AZ-07)
[phone] office, [phone] cell
www.grijalva.house.gov



++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

Testimonial: Southern Arizona Attractions Alliance



www.tucsonattractions.com

"Our non-profit organization has had the pleasure of working with AudioEye for several years now and we greatly appreciate their innovative products and services that have enabled us to creatively showcase our organization online. Working with non-profits is not always easy, but they have always given us excellent customer service and have been generous and flexible with their time and talent in accommodating our requests on a limited budget."

Catherine M. Strickland?
Marketing Program Manager
Pima County Attractions
33 N. Stone Avenue, Suite 830 Tucson, AZ 85701
Phone: [phone] Fax: [phone]
www.tucsonattractions.com



++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

Testimonial: Samanvai Center for Children with Multiple Disabilities



www.samanvai.org

It’s my pleasure to work with AudioEye and their customer friendly staff. Samanvai center for children with multiple disabilities based in Hyderabad, India approached AudioEye to utilize its patented accessibility software. We are the first organization to provide this software for Indian print impaired users. We received good feedback from site users who are very happy with the incorporation of this product on our site. This product is providing accessible user experience even in the Internet centers. We at samanvai really think this software is the breakthrough in this twenty first century to solve accessibility requirements for visually impaired people. I strongly recommend all organizations to use this licensed software to support and improve the web accessibility. If big companies like Google use this software, then the problems of web accessibility can be solved. We will continue to provide our feedback on this product to make it better. Thank you so much!

Srikanth Bolla,
Co-founder
samanvai center for children with multiple disabilities
www.samanvai.org



++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

1 Day Chart


1 Month Chart


++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++

$AEYE

[qwertytrader]

$JCP - keep an eye on it, it may have found bottom and now working its way up

if the economy and market stay on the "up and up" (I use that loosely) then numbers should reflect that, and that's the win

[qwertytrader]

$BAC still moving along



$BAC

[qwertytrader]

$ARNA on watch



$ARNA

[qwertytrader]

$DRL on watch



$DRL

[qwertytrader]

Colorado Lawmakers Set Taxes And Rules For Marijuana Sales

http://www.npr.org/blogs/thetwo-way/2013/05/09/182604241/colorado-lawmakers-set-taxes-and-rules-for-marijuana-sales
by Bill Chappell
May 09, 2013 1:09 PM

Colorado is set to become the first U.S. state to regulate and tax sales of recreational marijuana, after lawmakers approved several bills that set business standards and rules. Legislators expect enforcement of the rules to be paid for by two taxes on marijuana — a 15 percent excise tax, and a 10 percent sales tax.

Other measures included in the package set limits on how much marijuana visitors to Colorado can buy (a quarter of an ounce), as well as a limit on how many cannabis plants a private citizen can grow (six).

Gov. John Hickenlooper has indicated he will sign the legislation, according to The Denver Post. Colorado voters first approved the legalization of pot for recreational use by people over age 21 in a ballot initiative last November.

Voters adopted a similar measure in Washington state, where plans for regulation and taxation are still being formed.

"The first legal marijuana should be on sale in Washington in March 2014," reports the Seattle Post-Intelligencer, "and Colorado will have its cannabis stores open as soon as Jan. 1."

Like all new Colorado taxes, voters must approve the new taxation system in a ballot initiative this autumn.

Other states are already taxing pot, but those levies cover medical marijuana. California reportedly raises more than $100 million a year on such sales.

The Colorado legislation adopted Wednesday also includes a requirement that "pot must be sold in child-resistant packages with labels that specify potency," The Post reports. "Edible marijuana products will have serving-size limits."

[qwertytrader]

$MARA now on stockcharts.com

From: "StockCharts.com Support" <[e-mail]>
Date: May 6, 2013, 11:57:05 AM EDT
To: qwertytrader
Subject: Your Symbol Request Was Processed (StockCharts.com)

Thank you for your recent symbol request.

Based on your suggestion, we have added [MARA] to our charting database:
http://stockcharts.com/h-sc/ui?s=mara

Thanks for using StockCharts.com,
StockCharts Support
[e-mail]
http://stockcharts.com



$MARA

[qwertytrader]

$AEYE - First Week Of Trading



Date Open High Low Close Volume Adj Close
2013/05/02 1.00 1.10 0.91 1.10 9,115 1.10
2013/05/01 1.05 1.20 1.01 1.20 7,996 1.20
2013/04/30 1.50 1.50 1.00 1.29 12,633 1.29
2013/04/29 1.20 1.50 1.20 1.40 12,916 1.40
2013/04/26 0.51 3.00 0.51 1.12 9,653 1.12

$AEYE

[qwertytrader]

$ARNA after hours drop -17.74% on 2,459,394 shares to end at $6.91

nasty drop from 8.39 at the closing bell - news wasn't taken well

interesting to see what how the CC will help in the recover tomorrow....or will it be a continued fall?

http://www.nasdaq.com/quotes/after-hours.aspx

[qwertytrader]

CBIS DD & Quick Info Sheet

iHub Board

http://investorshub.advfn.com/Cannabis-Science-Inc-CBIS-7105/

Quote

http://ih.advfn.com/p.php?pid=squote&symbol=CBIS

Company Website

http://cannabisscience.com/

SEC Filings

http://www.sec.gov/cgi-bin/browse-edgar?company=Cannabis+science&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


------------------------------------------------------------------
------------------------------------------------------------------

CBIS Cancer Treatment Review

Cannabis Science Receives New Photos & Information on Patient Three’s Previous Examinations & the Current Progress on his S...

May 16, 2012

….Cannabis Science continues to work closely with its third patient, who is self-treating his otherwise resistant Squamous Cell Carcinoma. The patient has seen dramatic improvements. He has been applying a topical cannabis extract to his cancer, and has seen a large reduction in the tumor masses. Dr. Melamede spoke with the patient this morning, who stated that 80% of the rim that remained from the large tumor on the left side of his head was now gone. The newly posted photo was from over a week ago…..

http://ih.advfn.com/p.php?pid=nmona&article=52446162
http://www.cannabisscience.com/download/patientthree_may162012_update7-1.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Receives New Photos & Positive Feedback from Patient Three & an Oncologist about his Severe Squamous Cell Ca…
April 11, 2012

Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide new photographs of the existing treatment for patient three who has a “worst case” of treatment resistant, Squamous Cell Carcinoma. Cannabis Science has received positive feedback from both the patient and his Oncologist. These photos show the progressive reduction of the tumor masses that has occurred within the months of treatment.

http://ih.advfn.com/p.php?pid=nmona&article=51963191
http://www.cannabisscience.com/download/patientthree_apr112012_update6.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Second Cancer Patient Receives Clean Biopsy Report Confirming the Biopsy is Free of Cancer Cells
April 4, 2012

Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is happy to report that patient #2, who had a Squamous cell carcinoma on her arm, has received her biopsy report. It confirms what was visually apparent from the photo-documentation on our website. Her biopsy was free of cancer cells and she will not need any surgical procedure. Nevertheless, the patient will continue with her self-administered topical application of extracts for a while longer to minimize any chance of any surviving cancer cells in areas beyond what was biopsied.

http://ih.advfn.com/p.php?pid=nmona&article=51905666

------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Cancer Tumors Continues to Shrink & Die as Apparent Pieces of the Dying Cancer Tumors Begin to Fall ...

March 8, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient with Clear Continued Improvement. This self-medicating patient has what his doctors describe as the worst case of squamous cell carcinoma the had ever seen. This patient’s tumors, while resistant to conventional treatment, continues to make obvious improvement with the use of cannabis extracts

http://ih.advfn.com/p.php?pid=nmona&article=51543613

http://www.cannabisscience.com/download/patientthree_mar72012_update5.pdf

OFFICIAL PHOTO RELEASE FROM CBIS

------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-Medicated Cannabis Patient
February 23, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient with Clear Continued Improvement. This self-medicating patient has what his doctors describe as the worst case of squamous cell carcinoma the had ever seen. This patient’s tumors, while resistant to conventional treatment, continues to make obvious improvement with the use of cannabis extracts

http://ih.advfn.com/p.php?pid=nmona&article=51327206

http://www.cannabisscience.com/download/patientthree_feb222012_update4.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------


Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair
February 7, 2012

Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to present the newest set of photographs showing evidence that the cancer cells appear to have been killed over the course of treatment from the 2nd self-administering cancer patient suffering from squamous cell carcinoma on her arm

http://ih.advfn.com/p.php?pid=nmona&article=51064492

http://www.cannabisscience.com/download/2ndpatient_casestudy_feb072012_update.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient
February 2, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to introduce a 4th cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results.

http://ih.advfn.com/p.php?pid=nmona&article=51011740

http://www.cannabisscience.com/download/patientfour_feb012012.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying & Areas That Are Now Pain
January 30, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts

http://ih.advfn.com/p.php?pid=nmona&article=50950966

http://www.cannabisscience.com/download/patientthree_jan302012_update2.pdf

OFFICIAL PHOTO RELEASE FROM CBIS






------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Updates Latest Remarkable Follow up Photographs Received from 3rd Cancer Patient
January 24, 2012

Today Cannabis Science receives the latest photographs for the 3rd self-administering cancer patient, mentioned in the previous news release dated, January 11, 2012. The treatment process is ongoing, but the results have been visually dramatic, the cannabis extracts have drastically shrunk some tumors and others are gone.

http://ih.advfn.com/p.php?pid=nmona&article=50870675

http://www.cannabisscience.com/download/patientthree_jan232012_update1.pdf

OFFICIAL PHOTO RELEASE FROM CBIS




------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents
January 19, 2012

PROCEDURE AND RESULTS
The series of photos below documents the disappearance of a biopsied squamous cell tumor after self-administration of topical cannabis extracts over a 3 month period. After treatment with cannabis extract, the tumor was expelled from below the surface, killed, and healed.

http://ih.advfn.com/p.php?pid=nmona&article=50813674

http://www.cannabisscience.com/download/2ndpatient_casestudy.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient
January 11, 2012

The first picture shows a large tumor protruding a few inches above the surface of the patient's skull prior to treatment. The cannabis-based extract was applied into the holes and the surrounding tissue that are seen in this patient’s scalp that extended down to the skull. The second photograph shows the patient's head after receiving one of many radiation treatments. Subsequent photos demonstrate what appears to be the cannabis extract drawing out, and killing the cancer cells from these lesions.

While this patient's self-administered treatment with cannabis extracts is still in progress, the results after just two weeks of treatment are dramatic. Some of the tumors have disappeared and others have significantly shrunk to a fraction of their original size. Simultaneously, the patient has had a significant decrease in pain, improved sleeping (the 1st full night of sleep in 3 years), as well as relief from the symptoms of multiple sclerosis that the patient also suffers from. This self-treatment is a work in progress.

Cannabis Science is showing the general public unbiased evidence as we acquire it independent of the final outcome. As the treatment continues, and physician determinations are made, we will continue to update you so that you can follow the effectiveness of this treatment as it progresses.

http://www.cannabisscience.com/news-a-media/press-releases/257-cbis-reports-apparent-success-for-3rd.html

OFFICIAL PHOTO RELEASE FROM CBIS




------------------------------------------------------------------
------------------------------------------------------------------

More Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed As Self Medicating Squamous Cell Carcinoma Patient Reports Continued Shrinking of Cancer Tumor
January 3, 2012

http://www.cannabisscience.com/news-a-media/press-releases/253-more-cbis-brand-extracts-successful.html

------------------------------------------------------------------
------------------------------------------------------------------

Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells
December 12, 2011

http://www.cannabisscience.com/news-a-media/press-releases/247-second-self-medicated-medical-cannabis.html

------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Provides Physician’s Documentation That Confirms Successful Treatment of Skin Cancer
April 6, 2011

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), US biotech company developing pharmaceutical cannabis products. On March 9, 2011 Cannabis Science announced that we would follow up our press release with medical documentation regarding the effectiveness of our cannabis extracts for treating skin cancer as was documented photographically in our earlier press release of February 22, 2011. We are pleased to announce that we have physician’s documentation that confirms the successful treatment of basal cell carcinoma that resulted from the application of a topical cannabis extract.

Please visit www.cannabisscience.com to view the “Breaking News” of the successful results and images of the self-administered cancer treatments along with the physician's documentation after 4pm EST., today.

Currently, there is a tremendous amount of controversy with respect to the effects that cannabinoids have on cancers. Endocannabinoids, phytocannabinoids, and synthetic cannabinoids have demonstrated cancer killing and anti-metastatic properties in tissue culture and in animal models. While formal, proper, FDA approved clinical trials that would prove or disprove the therapeutic potential of cannabis extracts for treating cancers; trials have not been carried out. Nevertheless, a significant number of anecdotal observations have accumulated that suggest people suffering from a variety of cancers appear to have been cured by ingesting what is known as “Rick Simpson's hemp oil”.
There is widespread ignorance regarding the endocannabinoid system by medical professionals and laymen alike. The first hint that an endocannabinoid system existed resulted from an experiment published in 1988. Because of the endemic political and social bias against medical cannabis, nurtured by decades of misinformation, Cannabis Science has chosen a path that we feel will have the greatest probability of successfully traversing the FDA approval process. Our initial test product will only be topical, and will be formulated to reduce any internal consumption and thus reduce any abuse potential. With these considerations in mind, we will initially seek FDA approval for topically applied cannabis extracts for the treatment of basal cell carcinoma, a common form of skin cancer.

According to the National Cancer Institute ( www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001827/), basal cell carcinoma is the most frequently occurring cancer in the United States. Because of the horrific impact that cancer in general has on so many people worldwide, Cannabis Science has decided to make basal cell carcinoma its first target for clinical trial.

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

CBIS Product and Revenue Review

Products First Available: 10/27/11 putting sales revenue in 2011 Q4

10K For Period Ending December 31, 2011


PR History Of Product Available (minus the first 2-3 fluff ones)

Cannabis Science Gets Set to Release “Phytiva” Its Newest Brand of Over-the-Counter Skin & Nutraceutical Product Lines
5/27/12

Cannabis Science Provides Product Line Guidance With Summary of Products In Development And Available On The Market Today
4/24/12

Cannabis Science Issues Potential Revenues And Market Data for the New Cannabis Science Brand OTC Products
3/02/12

Cannabis Science’s COO Dr. Afaneh Provides Guidance On The Newest Over The Counter Product Line To Be Released
3/01/12

Cannabis Science Chief Operating Officer Dr. Moe Afaneh, Pharm D., MBA, NRCC, Confirms Newest Cannabis Science Brand Product
2/24/12

Cannabis Science Negotiates Commercialization Deal to Bring Cannabis Science Brand Formulations Immediately into the Californ
12/14/11

Cannabis Science Confirms Two Extract-Based Formulations Are Both Available Now at Cannabis Therapeutics & Marisol Therapeuti
11/30/11

Cannabis Science Releases Second Cannabis-Extract-Based Formulation Available Now at Marisol Therapeutics, 922 Kimble Drive
11/23/11

Cannabis Science Prepares Release of Second Cannabis-Extract-Based Formulation Along with Official Facebook & Twitter Page Re...
11/09/11

Cannabis Science Releases First Cannabis-Extract-Based Formulation Available Now at Cannabis Therapeutics, 957 E. Fillmore St...
10/27/11

------------------------------------------------------------------
------------------------------------------------------------------

$CBIS
Find CBIS News at
www.cannabisscience.com
Cannabis Science Inc.
Trading Symbol: CBIS

[qwertytrader]

Big Board Plays and Watch List


$AA
$ARNA
$BAC
$CEP
$DRL
$ENTR
$EGT
$GTAT
$HA
$HUN
$MO
$MSG
$NVE

New to My watch list so still learning these

$JCP
$LMT
$MSFT
$WSM
$YHOO

[qwertytrader]

$BAC bulls were in force the last few days leading to the uptrend continuance.

there is room to the up side before profit takers have to step in but with tomorrow being Friday it could be battle.

I saw the ask @ 2x1 today so tomorrows action, if down shouldn't drift far. If to the up side, it could gap to as high as 12.70 (talk about balls lmao)

we shall see....

I see more up side here. the more action I see the higher my target pps goes. this is Bank of America......that name carries more weight then just the company

play it close, I like it



$BAC

[qwertytrader]

$BAC Bank of America Corp 12.31 up 0.24 (1.99%)
Volume: 120,624,863

1 Day


$BAC

[qwertytrader]

Edison Award Info Recap: AudioEye Accessibility Platform




Link: http://www.edisonawards.com/index.php

Quality Of Life Nominees:
• Audioeye™ Accessibility Platform by Audioeye™, Inc.
• M.I. Dengue® by Ecovec S.A.
• Tuungane Project by The Nature Conservancy
• Twin Wing Tsunami Barrier by Van der Noort Innovations BV




Founded in 2003, AudioEye, Inc. (AudioEye) ...

AudioEye is focused on innovation and creating voice driven technologies that will improve the mobility, usability and accessibility of all Internet based content. We offer our solutions in three distinct product groups:
• AudioEye Mobile
• AudioEye Internet
• AudioEye Technology Licensing

Our company is headquartered at the University of Arizona Science and Technology Park in Tucson, Arizona and maintains business development office in the John Hancock building in Chicago, Illinois.

What is AudioEye Technology?

AudioEye is a breakthrough patented voice infrastructure technology.

Our patented technology dramatically expands the power and functionality of the voice-controlled browser. Voice recognition and artificial intelligence engines provide a partial solution, allowing users to get an "answer" to a specific question. Our patented technologies enable an essential third ingredient – delivering audio menus that allow users to choose among multiple responses and navigate the Internet via keypad or voice just as they would with familiar mouse/icon or gestural interfaces.

Our technology Platform, when connected to voice recognition and artificial intelligence engines, can provide for a fully Audio Internet (TM) experience complete with voice navigation and voice driven transactions. Everything the Internet can do AudioEye can do better without the use of a visual display, mouse, or touch pad.

Contact Information
CORPORATE
University of Arizona
Science & Technology Park
9070 S. Rita Road, Suite 1450
Tucson, Arizona 85747
Toll Free: 866.331.5324
Fax: [phone]
[e-mail]

$AEYE

[qwertytrader]

$BAC Bank of America Corp 12.07 Up 0.35 (2.99%)
Volume: 176,578,355

[qwertytrader]

$CMGO spin off AudioEye $AEYE

should start trading soon

Opening action should be interesting

[qwertytrader]

$AEYE - AudioEye Inc - $CMGO spin off company



Corporate Web Page:
http://www.audioeye.com/

iHub Board
http://investorshub.advfn.com/AudioEye-Inc-AEYE-26369/

OTCMarkets
http://www.otcmarkets.com/stock/AEYE/quote


OTCBB
http://www.otcbb.com/asp/Info_Center.asp

$AEYE $CMGO

[qwertytrader]

hey friend - im doing well. keeping busy with work and life. Looking forward to the great spring weather and summer.

[marirstk]

Good morning my friend..

How are you? Didnt see u post in a while?

Everything ok?

$EGT is on the move.. Target is 7-8$

[qwertytrader]

The Speakeasy Supports The Electric Daisy Carnival and will be attending the NY show






Link: http://electricdaisycarnival.com/NewYork/

[qwertytrader]

Yahoo added to the radar

[qwertytrader]

Microsoft added to the radar

[qwertytrader]

$GTAT - bounced nicely off of 2.60

with the right support right now it could trend to 4.30~

otherwise retrace test to ~3.00

IMO

[qwertytrader]

$DRL solid day yesterday - watch the action closely